August 22, 2004
New Cancer Drug for Pleural Mesothelioma
A new treatment for asbestos-related lung cancer has been registered for use in New Zealand.
Alimta (Pemetrexed) has been shown to extend the life expectancy of patients with malignant pleural mesothelioma an average of 12 months, compared with six to eight months on existing treatments. (New Zealand Herald)